Published in Cancer Weekly, October 7th, 1996
The respondents' concerns may be valid: Statistics show that, on average as many as 20 percent of all cancers in the U.S. defy classification by standard methods, resulting in incorrect or ineffective treatment, unnecessary complications, and increased cost.
The survey, commissioned by Impath, New York, New York, questioned 1,007 Americans 18 and over about issues and concerns related to the diagnosis and treatment of cancer in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.